Skip to main content

Home/ Cancer/ Group items tagged AMG479

Rss Feed Group items tagged

Matti Narkia

Experimental insulin-like growth factor receptor inhibitor reduced pancreatic cancer gr... - 0 views

  •  
    PHILADELPHIA - Researchers at Amgen are testing a fully human monoclonal antibody that inhibits the activity of insulin-like growth factors (IGF-1 and IGF-2) and appears to reduce pancreatic cancer cells in early testing, according to a report in Molecular Cancer Therapeutics, a journal of the American Association for Cancer Research.
1 - 1 of 1
Showing 20 items per page